# Impact of Full Correction of PTA in Renal Transplant Recipients

> **NCT03861637** · NA · COMPLETED · sponsor: **Hamid Al-Essa Organ Transplant Center** · enrollment: 280 (actual)

## Conditions studied

- Anemia

## Interventions

- **OTHER:** ESA for correction of PTA to 12-13g/dl

## Key facts

- **NCT ID:** NCT03861637
- **Lead sponsor:** Hamid Al-Essa Organ Transplant Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-20
- **Primary completion:** 2018-12-20
- **Final completion:** 2018-12-20
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2019-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03861637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03861637, "Impact of Full Correction of PTA in Renal Transplant Recipients". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03861637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*